elvitegravir
SpainDrugs containing this active substance
-
It is used for the treatment of human immunodeficiency virus (HIV-1) infection in adults, adolescents, and children aged 6 years or older weighing at least 25 kg. It helps reduce the amount of virus in the body to improve the immune system.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir alafenamide 10 mg elvitegravir 150 mg cobicistat 150 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used to treat human immunodeficiency virus (HIV) infection in adults and adolescents aged 12 to 18 years who weigh at least 35 kg and who have previously received other HIV treatments that caused side effects.
Form: tablets, film-coated
Active substance Dosage cobicistat 150 mg emtricitabine 200 mg tenofovir disoproxil fumarate 245 mg elvitegravir 150 mg Manufacturer: Gilead Sciences Ireland Unlimited Company